These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12222702)

  • 1. Covered stent graft for primary PTCA of an aortocoronary vein graft.
    Timurkaynak T; Ciftci H; Cengel A
    Acta Cardiol; 2002 Aug; 57(4):305-8. PubMed ID: 12222702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial.
    Stone GW; Goldberg S; O'Shaughnessy C; Midei M; Siegel RM; Cristea E; Dangas G; Lansky AJ; Mehran R
    JACC Cardiovasc Interv; 2011 Mar; 4(3):300-9. PubMed ID: 21435608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of saphenous vein graft stent implantation: single center results from use of oversized balloon catheters.
    Scavetta K; Oh C; Caldron R; Abdel-Dayem T; Al-Zaibag M; Jutzy KR; Marsa RJ; Sjolander M; Ribeiro PA
    Angiology; 1999 Nov; 50(11):891-9. PubMed ID: 10580353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedural results and distal embolization after saphenous vein graft stenting and angioplasty for in-stent restenosis of grafts.
    Cicek D; Doven O; Pekdemir H; Camsari A; Akkus NM; Cin GV; Parmaksiz T; Katircibasi T
    Jpn Heart J; 2004 Jul; 45(4):561-71. PubMed ID: 15353867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial.
    Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Holper EM; Haagen D; Saeed B; Iturbe JM; Shunk K; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S; Brilakis ES
    JACC Cardiovasc Interv; 2009 Sep; 2(9):855-60. PubMed ID: 19778774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.
    Brilakis ES; Lichtenwalter C; Abdel-karim AR; de Lemos JA; Obel O; Addo T; Roesle M; Haagen D; Rangan BV; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S
    JACC Cardiovasc Interv; 2011 Feb; 4(2):176-82. PubMed ID: 21349456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distal embolization after net protective stent (MGUARD) implantation in a degenerated saphenous vein graft lesion.
    Yassin I; Thuesen L
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):639-41. PubMed ID: 20091812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane-covered stents for the treatment of aortocoronary vein graft disease.
    Baldus S; Köster R; Reimers J; Hamm CW
    Catheter Cardiovasc Interv; 2000 May; 50(1):83-8. PubMed ID: 10816288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up results after interventional treatment of infarct-related saphenous vein graft occlusion.
    Hoffmann R; Nitendo G; Deserno V; Adamu U; Almalla M; Blindt R; Vogt F
    Coron Artery Dis; 2010 Mar; 21(2):61-4. PubMed ID: 20124993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of the Symbiot PTFE-covered stent to reduce distal embolization during percutaneous coronary intervention in saphenous vein grafts.
    Blackman DJ; Choudhury RP; Banning AP; Channon KM
    J Invasive Cardiol; 2005 Nov; 17(11):609-12. PubMed ID: 16264208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary use of embolic protection devices in saphenous vein graft interventions: Insights from the stenting of saphenous vein grafts trial.
    Badhey N; Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Addo TA; Haagen D; Abdel-Karim AR; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger PB; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):263-9. PubMed ID: 20665875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program.
    Brilakis ES; Lasala JM; Cox DA; Berger PB; Bowman TS; Starzyk RM; Dawkins KD
    JACC Cardiovasc Interv; 2010 Jul; 3(7):742-50. PubMed ID: 20650436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined distal embolization protection and rheolytic thrombectomy to facilitate percutaneous revascularization of totally occluded saphenous vein grafts.
    Gaitonde RS; Sharma N; von der Lohe E; Kalaria VG
    Catheter Cardiovasc Interv; 2003 Oct; 60(2):212-7. PubMed ID: 14517927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography for the assessment of pericardium covered stents for the treatment of degenerated saphenous vein grafts.
    Tyczynski P; Kukreja N; van Geuns RJ; Wykrzykowska JJ; Sheppard MN; Di Mario C
    EuroIntervention; 2010 May; 6(1):78-85. PubMed ID: 20542801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary experiences using the MGuard stent platform in saphenous vein graft lesions.
    Vaknin-Assa H; Assali A; Kornowski R
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1055-7. PubMed ID: 19434749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential 1-year clinical outcomes for ST-segment elevation myocardial infarction related to stent thrombosis or saphenous vein graft thrombosis.
    Arzamendi D; Ly HQ; Tanguay JF; Armero S; Jilaihawi H; Gallo R; Ibrahim R; L'Allier P; Blondeau L; Gosselin G; Gregoire J; Doucet S
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):193-200. PubMed ID: 21805615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protection.
    Ashby DT; Dangas G; Aymong EA; Iakovou I; Kuepper F; Mehran R; Stone GW; Leon MB; Moses JW
    J Am Coll Cardiol; 2003 Mar; 41(5):749-52. PubMed ID: 12628717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate evidence of the benefit of distal protection in vein graft intervention.
    Porto I; Cautilli G; Camaioni C
    J Cardiovasc Med (Hagerstown); 2012 Dec; 13(12):828-9. PubMed ID: 21670703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of adverse events during saphenous vein graft intervention with distal embolic protection: a PRIDE substudy.
    Kirtane AJ; Heyman ER; Metzger C; Breall JA; Carrozza JP
    JACC Cardiovasc Interv; 2008 Apr; 1(2):186-91. PubMed ID: 19463299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiographic and clinical outcomes following acute infarct angioplasty on saphenous vein grafts.
    Watson PS; Hadjipetrou P; Cox SV; Pyne CT; Gossman DE; Piemonte TC; Eisenhauer AC
    Am J Cardiol; 1999 Apr; 83(7):1018-21. PubMed ID: 10190512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.